Securities Code: 300759
Securities Abbreviation: Kanglong Chemical
Announcement No.: 2026-016
Kanglong Chemical (Beijing) New Drug Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
On March 30, 2026, the Company held the 19th meeting of the 3rd Board of Directors, where it reviewed and approved the proposal on increasing registered capital and amending the Articles of Association. The specific content is announced as follows: